News
TSH Biopharm Expands Rare Disease Portfolio, Unlocks New Opportunities in CNS Market
2025.5.6
...
More
Double Milestone for TSH Biopharm: Top 5% in Corporate Governance and Product Expansion into Macau
2025.5.1
...
More
To announce the change of internal audit officer.
2025.4.30
...
More
To announce the change of internal audit officer.
2025.4.18
...
More
Announcement on behalf of major subsidiary, CHUANG YI BIOTECH CO., LTD.,of executive personnel change
2025.3.24
...
More
TSH Biopharm was invited to attend the institutional investor conference hosted by Reliance Securities
2025.3.13
...
More